A novel age-informative polygenic score improves predictive ability for kidney function and kidney function decline
Janina M. HeroldiD, Simon Wiegrebe, Barbara ThorandiD, Thomas W. WinkleriD, C Gieger, Florian HartigiD, M. Behr, Annette PetersiD, Helmut KüchenhoffiD, Iris M. HeidiD
Abstract
Polygenic scores (PGSs) are widely used to summarize the joint genetic effects for disease-related traits. However, while age-dependent genetic effects are increasingly recognized, their integration into PGSs remains underexplored. Kidney function, assessed by estimated glomerular filtration rate (eGFR), has strong age-related genetic effects, and prediction of kidney function decline is an unmet need. We develop an age-informative PGS for quantitative traits by generating age-specific weights via main and interaction effects and compare its performance to the age-agnostic PGS in theory and real data of eGFR. We test PGSs across 282 kidney function SNPs in cross-sectional and longitudinal data from UK Biobank (n=348,275, m=1,520,382) and independent population-based individuals aged 25 to 98 years (KORA&AugUR; n=9,057, m=16,804). In theory and real data, we illustrate that ignoring age mis-specifies genetic effects. The age-informative PGS has better performance than the age-agnostic PGS in young and old individuals (KORA&AugUR: 6.3% versus 5.9% of eGFR variance in 25-to 45-year-old, 2.3% versus 1.8% in 75-to 98-year-old). The PGS based on interaction effects explains more of the eGFR-decline variability than the age-agnostic PGS. The highest versus lowest PGS quintile predict eGFR-decline of -0.88 (95%-CI=[-0.93;-0.83]) versus -0.75 ml/min/1.73m2 (95%-CI=[-0.79;-0.71]) on the population-level, similar to strata by acquired risks like diabetes, obesity or albuminuria. Prediction of eGFR-decline on the individual level remains challenging by both, genetic or acquired risks. Overall, we provide a simple approach to an age-informative PGS for quantitative disease traits and illustrate its chances and challenges for predicting kidney function and kidney function decline.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A Polygenic Score for Reduced Kidney Function and Adverse Outcomes in a Chronic Kidney Disease Cohort
Inga Steinbrenner, Zhi Yu, … Anna Köttgen·Kidney InternationalPeer-reviewed·Dec 5, 2022
- Polygenic Risk Scores for Kidney Function to the Circulating Proteome, and Incident Kidney Diseases: the Atherosclerosis Risk in Communities Study
Zhi Yu, Jin Jin, … Josef Coresh·bioRxiv·Sep 5, 2020
- Discovery of genomic and transcriptomic pleiotropy between kidney function and soluble receptor for advanced glycation end-products using correlated meta-analyses: The Long Life Family Study (LLFS)
Mary Furlan Feitosa, Shiow J. Lin, … Michael A. Province·Aging CellPeer-reviewed·Jun 26, 2024
- Polygenic predictors of age-related decline in cognitive ability
Stuart James Ritchie, William David Hill, … Ian J. Deary·Molecular PsychiatryPeer-reviewed·Feb 13, 2019
- Accelerated epigenetic aging and inflammatory/immunological profile (ipAGE) in patients with chronic kidney disease
Igor Yusipov, Elena V. Kondakova, … Mikhail Ivanchenko·GeroSciencePeer-reviewed·Mar 2, 2022
- Multimodal predictions of end stage chronic kidney disease from asymptomatic individuals for discovery of genomic biomarkers
Simona Rabinovici‐Cohen, Daniel E. Platt, … Pablo Meyer·BMC NephrologyPeer-reviewed·May 12, 2026